113 related articles for article (PubMed ID: 38065745)
1. Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
Baylan B; Ulusoy K; Ekenci B; Kartal IG
Asian J Surg; 2024 Mar; 47(3):1360-1365. PubMed ID: 38065745
[TBL] [Abstract][Full Text] [Related]
2. Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy.
Wang S; Ji Y; Ma J; Du P; Cao Y; Yang X; Yu Z; Yang Y
Front Oncol; 2022; 12():1079622. PubMed ID: 36713540
[TBL] [Abstract][Full Text] [Related]
3. Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance.
Shelton TM; Greenberg JW; Silberstein JL; Krane LS
Aging Male; 2020 Dec; 23(5):1400-1408. PubMed ID: 32500781
[TBL] [Abstract][Full Text] [Related]
4. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
Front Oncol; 2022; 12():907625. PubMed ID: 35719913
[TBL] [Abstract][Full Text] [Related]
5. Prostate volume effect on Gleason score upgrading in active surveillance appropriate patients.
Çamur E; Coşkun A; Kavukoğlu Ӧ; Can U; Kara Ö; Develi Çamur A; Sarıca K; Narter KF
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266273
[TBL] [Abstract][Full Text] [Related]
6. Is neutrophile to lymphocyte ratio a predictor of Gleason score upgrading according to risk classifications in patients with prostate cancer.
Karadağ S; Ekşi M; Özdemir O; Akkaş F; Arikan Y; Özlü DN; Çolakoğlu Y; Aliş D; Şahin S; Tuğcu V
Arch Esp Urol; 2021 Jul; 74(6):599-605. PubMed ID: 34219063
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
Özsoy M; Moschini M; Fajkovic H; Soria F; Seitz C; Klatte T; Gust K; Briganti A; Karakiewicz PI; Roupret M; Kramer G; Shariat SF
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):100-105. PubMed ID: 29230007
[TBL] [Abstract][Full Text] [Related]
8. The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
Verep S; Erdem S; Ozluk Y; Kilicaslan I; Sanli O; Ozcan F
Prostate; 2019 Sep; 79(13):1523-1529. PubMed ID: 31269285
[TBL] [Abstract][Full Text] [Related]
9. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study.
Wang S; Ji Y; Chen Y; Du P; Cao Y; Yang X; Ma J; Yu Z; Yang Y
Front Oncol; 2021; 11():812319. PubMed ID: 35047413
[TBL] [Abstract][Full Text] [Related]
10. Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance.
Gokce MI; Tangal S; Hamidi N; Suer E; Ibis MA; Beduk Y
Can Urol Assoc J; 2016; 10(11-12):E383-E387. PubMed ID: 28096923
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
Ferro M; Musi G; Serino A; Cozzi G; Mistretta FA; Costa B; Bianchi R; Cordima G; Luzzago S; Di Trapani E; Tagliabue E; Vartolomei MD; Terracciano D; Cassatella MC; Salvatici M; Conti A; Sandri MT; Cioffi A; Turetti M; Catellani M; Bottero D; Matei DV; Mirone V; de Cobelli O
Urol Int; 2019; 102(1):43-50. PubMed ID: 30408799
[TBL] [Abstract][Full Text] [Related]
12. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
Kim H; Jung G; Kim JH; Byun SS; Hong SK
Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
Pham DM; Kim JK; Lee S; Hong SK; Byun SS; Lee SE
Investig Clin Urol; 2020 Jul; 61(4):405-410. PubMed ID: 32665997
[TBL] [Abstract][Full Text] [Related]
14. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort.
Zhang B; Wu S; Zhang Y; Guo M; Liu R
Cancer Med; 2021 Nov; 10(21):7772-7780. PubMed ID: 34528767
[TBL] [Abstract][Full Text] [Related]
16. A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer.
Blute ML; Shiau JM; Truong M; Shi F; Abel EJ; Downs TM; Jarrard DF
World J Urol; 2017 May; 35(5):729-735. PubMed ID: 27631325
[TBL] [Abstract][Full Text] [Related]
17. Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer.
Rajwa P; Schuettfort VM; D'Andrea D; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Huebner N; Aulitzky A; Mun DH; Briganti A; Karakiewicz PI; Fajkovic H; Shariat SF
Urol Oncol; 2021 Nov; 39(11):785.e19-785.e27. PubMed ID: 34116934
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
19. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
20. Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.
Zhang JY; Ge P; Zhang PY; Zhao M; Ren L
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
